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Mast cells are secretory cells that play an important role in
host defense by discharging various intragranular contents,
such as histamine and serotonin, upon stimulation of Fc recep-
tors. The granules also contain spermine and spermidine, which
can act as modulators of mast cell function, although the mech-
anismunderlying vesicular storage remains unknown.Vesicular
polyamine transporter (VPAT), the fourth member of the
SLC18 transporter family, is an active transporter responsible
for vesicular storage of spermine and spermidine in neurons. In
the present study, we investigated whether VPAT functions in
mast cells. RT-PCR and Western blotting indicated VPAT
expression in murine bone marrow-derived mast cells (BMMCs).
Immunohistochemical analysis indicated that VPAT is colocal-
ized with VAMP3 but not with histamine, serotonin, cathepsin
D, VAMP2, or VAMP7.Membrane vesicles from BMMCs accu-
mulated spermidine upon the addition of ATP in a reserpine-
and bafilomycin A1-sensitive manner. BMMCs secreted sperm-
ine and spermidine upon the addition of either antigen or
A23187 in the presence of Ca2, and the antigen-mediated
release, which was shown to be temperature-dependent and
sensitive to bafilomycin A1 and tetanus toxin, was significantly
suppressed by VPAT gene RNA interference. Under these con-
ditions, expression of vesicular monoamine transporter 2 was
unaffected, but antigen-dependent histamine releasewas signif-
icantly suppressed, whichwas recovered by the addition of 1mM
spermine.These results strongly suggest thatVPAT is expressed
and is responsible for vesicular storage of spermine and spermi-
dine in novel secretory granules that differ from histamine- and
serotonin-containing granules and is involved in vesicular
release of these polyamines frommast cells.
Mast cells are hematopoietic cells that play important roles
in the immune system. These cells exhibit unique morpholog-
ical features, with electron-dense secretory granules containing
large amounts of preformed and preactivated immunomodula-
tory compounds, such as histamine, serotonin, several mast
cell-specific proteases (tryptases and chymases), tumor necro-
sis factor (TNF), etc. (1–3). When mast cells are activated in
response to various external stimuli, such as cross-linking of
IgE bound to the high affinity IgE receptor, the intragranular
contents are discharged into the extracellular space through
degranulation and trigger various immunoreactions involved in
allergy, asthma, atherosclerosis, inflammatory arthritis, multi-
ple sclerosis, and cancer (1, 3).
In addition to biogenic amines, such as histamine and sero-
tonin, mast cells contain spermine and spermidine, polycations
that are known to play essential roles in cell survival and prolif-
eration in all organisms (4–6). These polyamines are stored in
mast cell secretory granules, appear in the extracellular space
through A23187-evoked Ca2-dependent processes, and are
thought to be involved in biogenesis and homeostasis of secre-
tory granules (4). Furthermore, it has been reported that sperm-
ine and spermidine, when applied to mast cells extracellularly,
facilitate synthesis and release of histamine from mast cells
(7–11). Spermine and spermidine are also involved in storage
and/or release of histamine and serotonin in themast cell gran-
ules (4, 12). Although there are numerous studies on polyamine
function inmast cells, it remains unclear how these polyamines
are loaded intomast cell granules anddischarged into the extra-
cellular space upon stimulation.
Vesicular storage of neurotransmitters is a charged process
of classical neurotransmitters in neuronal and neuroendocrine
cells, which consists of active transport that is energetically
coupled with a vacuolar proton pump. Vesicular neurotrans-
mitter transporters specific to the transmitters are responsible
for the storage of the respective neurotransmitters (13). Essen-
tially all transporters for the classical neurotransmitters have
been identified (i.e. vesicular monoamine transporters (SLC18A1
and -A2), vesicular acetylcholine transporter (SLC18A3), vesic-
ular GABA transporter (SLC32A1), vesicular glutamate trans-
porters (SLC17A6–A8), vesicular excitatory amino acid trans-
porter (SLC17A5), and vesicular nucleotide transporter
(SLC17A9), in order of identification) (14, 15).
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Vesicular polyamine transporter (VPAT)3 encoded by the
SLC18A4 (or SLC18B1) gene is the fourth member of the
SLC18 family. VPAT is present in secretory vesicles and is
responsible for vesicular storage of spermine and spermidine
followed by vesicular release of these polyamines from astro-
cytes (16). In the present study, we investigated whether VPAT
is expressed in mast cells and whether it contributes to the
storage of polyamines in mast cell granules. We also examined
whether VPAT-dependent polyamine release contributes to
the release of other biogenic amine from mast cells. Here, we
report that polyamine storage in mast cells represents typical
chemical transmission mediated by VPAT.
Results
Expression of VPAT in Mast Cells—First, we investigated
whether bonemarrow-derivedmast cells (BMMCs) express the
VPAT gene.Maturation of BMMCswas confirmed by toluidine
blue staining and flow cytometry according to the published
procedures.More than 93%of cells inwhich themast cellmark-
ers, c-Kit and FcRI, were co-expressed were judged to be
mature BMMCs.As shown in Fig. 1a, a 179-kbVPAT transcript
was detected in BMMCs, whereas no such transcript was
detected in the RT control. Furthermore, VMAT2 gene
expression was also observed in BMMCs. Consistent with the
results reported previously, marginal levels of VMAT1 expres-
sionwere observed (17). Subsequently, we investigatedwhether
VPAT protein is actually expressed in BMMCs. Immunoblot-
ting with specific antibodies against mouse VPAT indicated
that the BMMC-derived membrane fraction contained an
immunoreactive polypeptide with an apparent molecular mass
of 55.6 kDa, which disappeared with preabsorption of anti-
VPAT antisera (Fig. 1b). The anti-VPAT antibody detected
immunoreactive protein bands in the astrocytemembrane frac-
tion, as reported previously (16) (Fig. 1b). Furthermore, immu-
nohistochemical analysis with anti-VPAT antibody indicated
that BMMCs were immunoreactive, and internal particle-like
structures showed strong staining, whereas preabsorbed anti-
bodies did not recognize these structures (Fig. 1c). In astrocytes,
VPAT immunoreactivity was present in the cytoplasm, as
reported previously (16) (Fig. 1c). Taken together, these results
indicated that BMMCs express not only VMAT2 but also
VPAT.
Localization of VPAT in BMMCs—The observations that
mast cells contain numerous secretory granules and BMMCs
possess VPAT-immunoreactive particle-like structures suggest
that VPAT is localized to secretory granules. Double immuno-
fluorescence microscopy indicated that a major population of
VPAT immunoreactivity was not co-localized with histamine,
serotonin, and cathepsin D (Fig. 2a). VPAT was colocalized
with spermine synthase, as confirmed by staining with specific
antibodies against spermine synthase (Fig. 2a). Another series
of double immunoreactivity experiments indicated that VPAT
immunoreactivity is co-localized with VAMP3 but not with
VAMP2 and VAMP7 (Fig. 2b). Partial co-localization was
observed with VAMP8 (Fig. 2b). Furthermore, VPAT was not
co-localized with LAMP1 or GM130, markers of the lysosome
and Golgi apparatus, respectively (Fig. 2c). These results sug-
gested that VPAT-containing organelles do not match hista-
mine-containing secretory granules and serotonin-containing
secretory granules.
Vesicular Polyamine Storage—Like other classical neuro-
transmitter transporters, VPAT mediates active transport of
spermine and spermidine at the expense of a proton motive
force established by vacuolar proton ATPases (16). To investi-
gate whether VPAT in BMMCs is functional, we prepared
membrane fractionofpostnuclear fractionofBMMCsandmea-
sured ATP-dependent spermidine uptake. As shown in Fig. 3,
the addition of ATP facilitated spermidine uptake, which was
inhibited by 1M reserpine, an inhibitor of VMATs andVPAT,
and by 0.5 M bafilomycin A1, a specific inhibitor of vacuolar
proton ATPase (Fig. 3a). Furthermore, the ATP-dependent
spermidine uptake was inhibited by an excess (5 mM) of sperm-
ine, spermidine, and histamine. Serotonin had a weak inhibi-
tory effect compared with the other amines (Fig. 3b).
BMMCs Release Polyamines—It is expected that vesicular
polyamines are released from BMMCs upon stimulation. As
shown in Fig. 4, IgE-mediated antigen stimulation facilitated
3 The abbreviations used are: VPAT, vesicular polyamine transporter; BMMC,
bonemarrow-derivedmast cell; RPMC, rat peritonealmast cell; VAMP, ves-
icle-associated membrane protein; VMAT, vesicular monoamine trans-
porter; mVPAT, mouse VPAT; Ab, antibody; G3PDH, glyceraldehyde
3-phosphate dehydrogenase.
FIGURE 1.VPATgene andprotein expression in BMMCs. a, RT-PCR analysis
was performed to examine the expression of VPAT (179 bp), VMAT1 (123 bp),
and VMAT2 (141 bp) mRNAs in BMMCs. The PCR product from brain mRNA is
shownas apositive control. Expressionof theG3PDHgene is also shownas an
RNA quality control (150 bp). b, Western blotting with anti-VPAT antibodies
indicated the presence of VPAT protein in the BMMC granule fraction (4 g).
The astrocyte membrane fraction (30 g) is also shown as a positive control.
Preabsorbed antibodieswere used in the BMMCgranule fraction as a control.
The position of VPAT protein is indicated by an arrow. c, indirect immunoflu-
orescencemicroscopy revealed that VPATwas expressed inBMMCs.Apicture
of astrocytes is also shown as a positive control. Inset, control staining with
preabsorbed antibodies. Bars, 10 m.
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release of spermine and spermidine in a time-dependent man-
ner (Fig. 4a, closed circles). In the absence of stimulation, essen-
tially no or low levels of spermine and spermidine release were
observed (Fig. 4a, open circles). Time-dependent and IgE/
antigen-dependent release of histamine was also observed (Fig.
4a). The pattern of spermidine release was similar to that of
histamine but slightly different from that of spermine. In the
presence of extracellular EGTA, both IgE/antigen-evoked
spermine and spermidine release were abolished (Fig. 4b).
These observations indicated that IgE/antigen-evoked sperm-
ine and spermidine release are Ca2-dependent, as in the case
of histamine release (Fig. 4b). Ca2-dependent spermine and
spermidine release were also observed with the addition of
the Ca2 ionophore, A23187 (Fig. 4c). Bafilomycin A1, a
inhibitor of vacuolar proton ATPase, inhibited both IgE/an-
tigen-evoked spermine and spermidine (51.5 and 45.2% inhi-
bition, respectively) release compared with the control level
(Fig. 4d). The polyamine release from BMMCs exhibited
FIGURE 2. Localization of VPAT in BMMCs. a–c, BMMCswere fixed and subjected to double immunostainingwith antibodies to VPAT (green, left), histamine,
serotonin, cathepsin D, and spermine synthase (a); VAMP2, VAMP3, VAMP7, and VAMP8 (b); and LAMP1 and GM130 (c) (red,middle).Merged images (right) are
also shown. Areas surrounded by dotted lines are enlarged in insets. Arrowheads, merged regions. Bars, 10 m.
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temperature dependence. Both IgE/antigen-evoked sperm-
ine and spermidine release were also significantly reduced
when BMMCswere incubated at 20 or 4 °C (Fig. 4e). Further-
more, TeNT, a neurotoxin that degrades VAMP2 and
VAMP3, inhibited both IgE/antigen-evoked spermine and
spermidine release (53.7 and 43.5% inhibition, respectively)
(Fig. 4f). These results are consistent with the characteristics
of transmitter secretion through exocytosis and indicated
the involvement of exocytotic mechanisms in polyamine
secretion from BMMCs.
Involvement of VPAT in Vesicular Polyamine Storage and
Release—Next, we investigated whether VPAT is involved in
vesicular polyamine release using gene knockdown techniques.
As shown in Fig. 5a, gene knockdown specific for VPAT sup-
pressed its gene expression by 95% without affecting VMAT2
gene expression in BMMCs (Fig. 5a). Consistent with the
suppression of gene expression, VPAT immunoreactivity
in BMMCs was decreased, whereas immunoreactivity for
VMAT2 showed no changes (Fig. 5b). Under these conditions,
we prepared the membrane fraction from siRNA-treated
BMMCs and assayed spermidine uptake. As shown in Fig. 5c,
ATP-dependent spermidine uptake by the siRNA-treated
membrane fraction was abolished, suggesting that the VPAT
expressed in BMMCs is functional. We also found that 95%
of IgE/antigen-evoked release of spermine was inhibited in
siRNA-treated BMMCs (Fig. 5d, left). IgE/antigen-evoked
release of spermidine was also inhibited by gene knockdown,
although the degree of inhibition was not as strong as that of
spermine release (Fig. 5d). Unexpectedly, however, IgE/anti-
gen-evoked release of histaminewas also inhibited by 50%upon
suppression ofVPAT gene expression (Fig. 5d, right). This inhi-
bition was partially blocked when exogenous spermine was
included in the culturemedium at a concentration of 1mM (Fig.
5d, right). These results clearly indicated that VPAT gene
expression is positively related to vesicular spermine and sper-
midine storage and release.
Expression of VPAT and Vesicular Polyamine Release from
Rat Peritoneal Mast Cells (RPMCs)—Finally, we assessed the
expression of VPAT in RPMCs to determine whether its
expression is specific to BMMCs. As shown in Fig. 6, RT-PCR
analysis indicated that RPMCs also express VPAT as well as
VMAT2. RPMCs also expressVMAT1. Furthermore, both IgE/
antigen treatment and the addition of A23187 triggered
RPMCs to release spermine and spermidine. Thus, it is reasonable
to suggest that RPMCs are equipped with VPAT-mediated
machinery for storage and release of polyamines, similar to
BMMCs.
Discussion
In chemical transmission, classical neurotransmitters, such
as serotonin and glutamate, are first stored in the secretory
vesicles via vesicular neurotransmitter transporters and then
discharged through exocytosis upon stimulation. In addition to
secretion of various cytokines and proteases, mast cells are
known to be histaminergic and serotonergic in nature, store
these monoamines in secretory granules, and release them
upon stimulation (18). The secretion of biogenic amines is
involved in bronchoconstriction, vasodilation, and vascular
permeability, which are the chief physiological and pathological
roles of mast cells (1). In the present study, we added a novel
feature of mast cells (i.e. mast cells accumulate polyamines in
the subpopulation of secretory granules through VPAT-medi-
ated active transport and subsequently secrete them upon
stimulation).
This conclusion was based on the following observations.
First, VPAT is expressed and associatedwith secretory granules
FIGURE 3. ATP-dependent spermidine uptake by membrane fraction of BMMCs. a, the effects of 1 M reserpine (an inhibitor of VMATs) and 0.5 M
bafilomycin A1 (an inhibitor of V-ATPase) on spermidine uptake by membrane fraction of BMMCs (25 g/assay) after 10 min. b, cis-inhibition of spermidine
uptake after 10 min. The additions were spermine, spermidine, serotonin, and histamine (all at 5 mM). Spermidine uptake in the absence of ATP is shown as a
negative control. Data are means S.E. (error bars); n 4–7 technical replicates. Essentially similar data were obtained from biological replicates (data not
shown). **, p 0.01; ***, p 0.001; N.D., not detected.
Vesicular Polyamine Transporter inMast Cells
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in mast cells. Second, the membrane vesicles prepared from
BMMCs can take up spermidine in an ATP-dependent and
reserpine-sensitivemanner, a known property of VPAT. Third,
inhibition of VPAT expression decreases the storage and
release of polyamines. Thus, VPAT is responsible for vesicular
storage of spermine and spermidine, followed by vesicular
release of these polyamines. Both spermine and spermidine are
synthesized from putrescine by spermidine synthase and
spermine synthase in a successive cascade. Because spermine
synthase and VPAT are co-localized in mast cells, these poly-
FIGURE 4. Polyamines were released through exocytosis from BMMCs. a, time courses of spermine (top), spermidine (middle), and histamine (bottom)
release from BMMCs in the presence (closed circles) or absence (open circles) of antigen. Data are means  S.E. (error bars); n  3–4 technical replicates.
Essentially similar data were obtained from biological replicates (data not shown). b, calcium dependence of polyamines and histamine release. BMMCs were
incubated in thepresence or absence of 1mMEGTA. c, time courses of spermine (left) and spermidine (right) release fromBMMCs in thepresence (closed circles)
or absence (open circles) of 2Mcalcium ionophore (A23187).d, effects of 1MbafilomycinA1onpolyamine release fromBMMCs. BMMCswerepretreatedwith
inhibitors for 2 h, followed by assay of IgE/antigen-evoked spermine (left) and spermidine (right) secretion. e, temperature dependence of polyamine release.
BMMCs were incubated and assayed for IgE/antigen-evoked spermine (left) and spermidine (right) secretion at the indicated temperature. f, effect of tetanus
toxin (TeNT) on polyamine release from BMMCs. BMMCs were treated with 10 g/ml TeNT for 36 h and assayed for IgE/antigen-evoked spermine (left) and
spermidine (right) secretion. Data are means S.E.; n 3–4 technical replicates. Essentially similar data were obtained from biological replicates (data not
shown). *, p 0.05; **, p 0.01; ***, p 0.001; N.D., not detected.
Vesicular Polyamine Transporter inMast Cells
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FIGURE 6. VPAT gene expression and polyamine release from RPMCs. a, RT-PCR analysis of SLC18 family and G3PDHmRNA expression in RPMCs. The PCR
product from brain mRNA is shown as a positive control. b, spermine (left) and spermidine (right) release from RPMCs stimulated with IgE/antigen or 2 M
calcium ionophore (A23187). Data are means S.E. (error bars); n 3–6 technical replicates. Essentially similar data were obtained from biological replicates
(data not shown). **, p 0.01; ***, p 0.001.
FIGURE 5. Effects of VPAT gene knockdown on endogenous expression of VPAT, polyamine storage, and release from BMMCs. For the VPAT gene
knockdown experiment, BMMCs were treated with VPAT-specific siRNA (RNAi) or AllStars negative control siRNA (control) as described under “Experimental
Procedures.” a, quantitative PCR analysis of VPAT (top) and VMAT2 (bottom)mRNA expression. Values are shown relative toG3PDH. Data aremeans S.E. (error
bars); n 3 technical replicates. Essentially similar data were obtained from biological replicates (data not shown). ***, p 0.001. b, immunohistochemical
detection of VPAT and VMAT2 in control or RNAi-treated BMMCs. Bars, 10 m. c, ATP-dependent spermidine uptake by membrane fraction derived from
RNAi-treated BMMCs. Spermidine uptake is shown relative to that in the absence of ATP (0.20 nmol/mg protein) as 100%. d, polyamine release from BMMCs
stimulatedwith IgE/antigen (left andmiddle). Histamine release fromBMMCs stimulatedwith IgE/antigen in the presence or absence of 1mM spermine (right).
Data aremeans S.E.;n 3–4 technical replicates. Essentially similar datawere obtained frombiological replicates (data not shown). *,p 0.05; **,p 0.01; ***,
p 0.001.
Vesicular Polyamine Transporter inMast Cells
3914 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 292•NUMBER 9•MARCH 3, 2017
 at Tsushim














amines formed in close proximity to VPAT-containing secre-
tory granules may be taken up effectively by VPAT and accu-
mulate inside granules.
Recently, it was reported that mast cells possess distinct
secretory granule subsets (2, 19, 20). Biochemical and histo-
chemical analyses clarified the presence of histamine-contain-
ing secretory granules and cathepsinD- and serotonin-contain-
ing secretory granules (20). Because VPAT can be regarded as a
molecular marker of polyamine-containing secretory vesicles,
identification of VPAT in mast cells would be very helpful to
characterize secretory granule subsets. In fact, the localization
of VPAT is different from those of histamine and serotonin,
suggesting that VPAT-containing secretory granules (i.e.
polyamine-containing secretory granules) is distinct from his-
tamine and serotonin granules. Recent studies indicated that
degranulation of secretory granule subsets is regulated by dif-
ferent SNARE isoforms (2, 20–23). In VAMP8 knock-outmice,
serotonin and cathepsin D release from BMMCs are signifi-
cantly reduced, whereas vesicular release of histamine is rather
stimulated (20). Pairs of cathepsin D and serotonin and sero-
tonin and VAMP 8 showed co-localization, whereas histamine
and serotonin did not (20). Another study demonstrated re-
duced histamine release from BMMCs derived from VAMP8
knock-out mice (21). In addition to VAMP8, VAMP7 is also
involved in histamine release, whereas VAMP3 is not required
for histamine release from human mast cells (22). We found
that both IgE/antigen-evoked spermine and spermidine release
were sensitive to TeNT, a neurotoxin that degrades VAMP2
andVAMP3but does not degradeVAMP7orVAMP8, suggest-
ing the involvement of VAMP2 or VAMP3 in exocytotic poly-
amine release from BMMCs (24–27). Our immunohistochem-
ical analyses indicated that VPAT is co-localized with VAMP3
andpartially co-localizedwithVAMP8, but notwithVAMP2or
VAMP7, further supporting the suggestion that VPAT-con-
taining granules (polyamine-containing granules) are distinct
from histamine granules and serotonin granules. Further char-
acterization of the VPAT-containing granules will be helpful
to understand the mechanism for regulating biogenic amines
release from mast cells.
It is well established that VMAT2 is specifically expressed in
mast cells and is responsible for vesicular storage and release of
histamine (17, 23). Furthermore, it is noteworthy that VMAT1
was also expressed in BMMCs and RPMCs (Figs. 1a and 6a).
Taken together with the association of SNARE complex out-
lined above, these results suggest that mast cell secretory gran-
ules may be much more heterogeneous than previously antici-
pated. The secretory granules of mast cells should be classified
from the viewpoint of the presence of VMAT1, VMAT2, and
VPAT. Such studies are currently under way in our laboratory.
It should be stressed that although VPAT gene knockdown
did not affect expression of VMAT2, it significantly suppressed
antigen-evoked histamine release (Fig. 5c). Furthermore, the
addition of spermine partially recovered the vesicular release of
histamine (Fig. 5c). These results explain the mode of action
of polyamines as autocrine or paracrine modulators; once
released, spermine and spermidine may act as intercellular mes-
sengers or chemical transmitters and facilitate the synthesis
and secretion of histamine. The action of polyamines implies
the presence of polyamine receptors in mast cells. It is well
known in other cell types, such as neuronal cells, that poly-
amines affect NMDA glutamate receptor activity (29, 30). In
mast cells, the NMDA receptor should be a candidate poly-
amine receptor, but the presence of NMDA receptors in these
cells is currently controversial (7, 9, 10). Another possibility is
the presence of an as yet unidentified polyamine-specific recep-
tor in mast cells. Compound 48/80, a polycationic histamine
releaser, evokes histamine release through Mrgprb2 (human
ortholog, MRGPRX2), which is inhibited by polyamines (31–
34). Thus, it has been reported that polyamine acts as an auto-
crine or paracrine transmitter through some type ofmembrane
protein and is associated with histamine release. Although the
hypothetical polyamine receptor has yet to be identified, char-
acterization of polyamine receptor may help to elucidate the
molecular mechanism of action of polyamine in mast cells.
In conclusion, we have demonstrated that VPAT is respon-
sible for vesicular storage and release of polyamines from mast
cells and that polyamine-containing secretory granules are dis-
tinct fromhistamine- and serotonin-containing secretory gran-
ules. Thus, our findings strongly suggest that secretory granules
are more heterogeneous in mast cells, and further functional
characterization of SLC18 family members will elucidate more
refined features of secretory granules in mast cells.
Experimental Procedures
PreparationofBMMCsandRPMCs—Male8-week-oldBALB/c
mice and male 7-week-old Wistar/ST rats were obtained from
Japan SLC (Shizuoka, Japan). All animal procedures and care
were approved by the institutional animal care and use com-
mittee and were carried out according to the guidelines of
Okayama University. BMMCs were prepared as described
previously (35). Briefly, bone marrow cells were isolated from
BALB/cmice. These cells were cultured in RPMI 1640medium
supplemented with 10% heat-inactivated FBS, 100 units/ml
penicillin, 100 units/ml streptomycin, 50 M 2-mercaptoetha-
nol, 0.1 mM non-essential amino acid solution, and 10 ng/ml
mouse IL-3. Medium was changed every 4–5 days, and cells
were used for experiments after 4–5 weeks of culture.
RPMCswere obtained fromWistar/ST rats as described pre-
viously (36). Briefly, rat peritoneal cells were recovered with
Tyrode-HEPES buffer (137 mM NaCl, 2.7 mM KCl, 1.6 mM
CaCl2, 1 mMMgCl2, 5.6 mM glucose, 10mMHEPES-NaOH, pH
7.4) containing 0.41 mM NaH2PO4 and 0.1% gelatin (THG
buffer) and centrifuged at 800  g for 3 min at 4 °C. The peri-
toneal cells were resuspended in 3 ml of THG buffer, layered
onto 1.5 ml of Tyrode-HEPES buffer containing 0.05% gelatin
and 22.5% (w/w)Histodenz (Sigma-Aldrich), and centrifuged at
45 g for 15 min at 4 °C. The cell pellet was washed twice with
PBS. Over 96% of the cells were confirmed to be RPMCs by
toluidine blue staining.
Flow Cytometry and Toluidine Blue Staining—Maturation of
BMMCs was assessed by analyzing the expression of mast cell
markers, FcRI and c-Kit, using flow cytometry and by toluidine
blue staining. For flow cytometric analysis, the cells were
washed and resuspended in staining medium (PBS supple-
mented with 7.7 mM sodium azide and 2% FBS) and blocked
with 16.7 g/ml rat anti-mouse FcRIII/FcRII Ab (clone
Vesicular Polyamine Transporter inMast Cells
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2.4G2; BDBiosciences) for 10min on ice. After incubationwith
12.5 g/ml mouse anti-dinitrophenyl mAb (clone SPE-7; Sig-
ma-Aldrich) for 50min on ice, cells were washed and incubated
with 2.5 g/ml rat anti-mouse IgE Ab conjugated with FITC
and 1 g/ml rat anti-mouse c-Kit Ab conjugated with PE or
isotype control Abs (all fromBDBiosciences) for 25min on ice.
Cells were washed and resuspended in staining medium con-
taining 50 g/ml propidium iodide for analysis with a FAC-
SCalibur flow cytometer using CellQuest software (BD Biosci-
ences). Over 93%of BMMCs showed coexpression of bothmast
cell markers. For toluidine blue staining, cells were stainedwith
2.5% toluidine blue solution (pH 3.3) for 15 min at room
temperature.
RT-PCR Analysis—Mouse and rat brain total RNAs were
purchased from Unitech (Chiba, Japan). Total RNAs were
isolated from BMMCs and RPMCs using an RNeasy minikit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. cDNAwas generated from1g of total RNAusing
a transcriptase kit (Toyobo, Osaka, Japan). Real-time PCR was
carried out with 400 nmol/liter specific forward and reverse
primers and 5 units/ml SYBR Premix ExTaq (Takara Bio, Otsu,
Japan). Thirty-five cycles of amplification were performed with
denaturation at 95 °C for 15 s and annealing/extension at 60 °C
for 30 s. The primer sets were as follows:mVPAT, 5	-TCGAG-
TGGGCAGCAGCTATG-3	 and 5	-CCAGAGCTCTCAAG-
GCTAGGTGTC-3	 (product size 179 bp);mVMAT1, 5	-GGA-
CAATATGCTGCTCACTGTGG-3	 and 5	-GTGAGAGCTT-
GCTGGGAGCTTAC-3	 (product size 123 bp);mVMAT2, 5	-
TACGGACTCATCGCTCCCAAC-3	 and 5	-GGCTACATC-
TGCAATGGCATACAC-3	 (product size 141 bp); rVPAT, 5	-
ACGGAATAAGTACGCTGGGACTTG-3	 and 5	-TAGCT-
GCTGCCCACTCGAAAC-3	 (product size 126 bp); rVMAT1,
5	-TTGGCTCATGGTCATCATTGG-3	 and 5	-CTGT-
GTACATCTGGGTCTCTGTGG-3	 (product size 137 bp);
rVMAT2, 5	-CCTTCGAAGTCCACCTGCTAA-3	 and 5	-
CATCACCGATGGGATATGACTG-3	 (product size 116 bp);
rVAChT, 5	-CGTGGATGAAGCACACAATGG-3	 and 5	-
CCTAACACGTGTGGCACGAAAG-3	 (product size 82 bp).
Mouse VPAT and VMAT2 expression were evaluated relative
to that of the housekeeping gene, glyceraldehyde 3-phosphate
dehydrogenase (G3PDH).
Antibodies—The immunological specificities of rabbit poly-
clonal antibodies against Glu429–Thr457 of mouse VPAT poly-
peptide prepared in housewere determined previously (16). Rat
polyclonal antibodies against mouse spermine synthase were
prepared by repeatedly injecting GST fusion polypeptides
encoding Ala178–Pro366 of mouse spermine synthase poly-
peptides into rats. The following antibodies were obtained
commercially: anti-histamine mouse monoclonal (Abcam,
Cambridge, UK), anti-serotonin mouse monoclonal (Dako,
Glostrup, Denmark), anti-cathepsin D goat polyclonal (Santa
Cruz Biotechnology, Inc., Dallas, TX), anti-VAMP2 mouse
monoclonal (Synaptic Systems, Göttingen, Germany), anti-
VAMP3 sheep polyclonal (Abcam), anti-VAMP7mousemono-
clonal (Abcam), anti-VAMP8 mouse monoclonal (Santa Cruz
Biotechnology), anti-LAMP1 mouse monoclonal (StressMarq
Biosciences, Victoria, Canada), anti-GM130mousemonoclo-
nal (BD Biosciences), anti-spermine rabbit polyclonal (Novus
Biologicals, Littleton, CO), and anti-spermidine rabbit poly-
clonal (Novus Biologicals) antibodies.
Immunofluorescence Microscopy—Indirect immunofluores-
cence microscopy was performed as described previously (37).
Briefly, BMMCs on poly-L-lysine-coated coverslips were fixed
with 4% paraformaldehyde in PBS for 30 min at room temper-
ature. The cells were washed with PBS and incubated with the
same buffer containing 0.02% saponin, 1% BSA, and 2% goat
serum or 0.02% saponin and 1% BSA for 15 min at room tem-
perature. The first antibody treatment was performed with
anti-mouse VPAT antibodies diluted 1:200 in PBS containing
0.5% BSA for 1 h at room temperature.Washing and secondary
antibody treatment were performed according to the published
procedures (37). The specimens were observed using an Olym-
pus FV300 confocal laser microscope.
Preparation of Granule Fraction and Membrane Fraction
from BMMCs—BMMCs were suspended in 20 ml of 10 mM
MOPS-Tris (pH 7.0) containing 0.3 M sucrose, 5 mM EDTA, 10
g/ml pepstatin A, and 10 g/ml leupeptin (SME buffer) and
then homogenized with a Dounce homogenizer. The homoge-
nate was disrupted by nitrogen cavitation after equilibration at
1000 p.s.i. for 10 min and centrifuged at 900  g for 8 min to
remove cell debris. To obtain the granule fraction, the resulting
supernatant was centrifuged at 10,000  g for 15 min. The
pellet was suspended in 1 ml of SME buffer and diluted with 19
ml of 8 mMMOPS/Tris (pH 7.0) buffer. After incubation on ice
for 30 min, the suspension was centrifuged at 10,000 g for 15
min. The resulting supernatant was centrifuged at 150,000 g
for 1 h. The pellet (granule fraction) was suspended in SME. To
obtain the membrane fraction, the supernatant obtained after
centrifugation at 900  g for 8 min was centrifuged at
100,000  g for 1 h. The pellet (membrane fraction) was sus-
pended in SME.
Spermidine Uptake—The membrane fraction (25 g of pro-
tein/assay) was suspended in 120 l of 20 mM MOPS-Tris (pH
7.0), 0.1 MKCl, 0.2 M sucrose, and 5mMmagnesium acetate and
incubated for 1min at 30 °C in the absence or presence of inhib-
itors. After incubation with 5 mM ATP for 1 min at 30 °C, the
assay was initiated by the addition of 100 M [3H]spermidine
(0.5 MBq/mol); aliquots of 100 l were taken at the indicated
times and filtered through 0.45-m nitrocellulose filters (Mil-
lipore, Billerica, MA). After washing with 6 ml of cold buffer
containing 20 mM MOPS-Tris (pH 7.0), 0.1 M KCl, 0.2 M
sucrose, and 5 mM magnesium acetate, the radioactivity
remaining on the filters was counted in a liquid scintillation
counter (PerkinElmer Life Sciences).
RNAi—AllStars negative control siRNA (Qiagen) ormVPAT
siRNA (SI01708707; Qiagen) at a concentration of 1 M was
transfected using a Nucleofector I device (Lonza, Basel, Swit-
zerland) set at program Y-01 with an Amaxa mouse macro-
phage nucleofector kit (Lonza) according to themanufacturer’s
instructions.mVPAT gene expression was assayed after 72 h.
Degranulation Assay—The cells were stimulated with anti-
gen or the calcium ionophore A23187. For antigen stimulation,
1  106 cells/ml of BMMCs were resuspended in RPMI
medium containing 1 g/ml mouse anti-dinitrophenyl mAb
(SPE-7) and incubated at 37 °C, 5% CO2 for 16 h. After washing
with Krebs-Ringer solution (128mMNaCl, 26mMNaHCO3, 10
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mM HEPES/Tris, pH 7.4, 2.4 mM CaCl2, 1.9 mM KCl, 1.3 mM
MgSO4, 1.2 mM KH2PO4) containing 0.2% BSA. The cells were
stimulated with 100 ng/ml DNP-HSA for 10 min at 37 °C, 5%
CO2. Supernatants were collected and stored at 80 °C until
use.
RPMCs were resuspended in Ringer’s solution containing 1
g/ml mouse anti-dinitrophenyl mAb (SPE-7) and incubated
for 1 h at 37 °C, 5% CO2. Then 2  105 cells were stimulated
with 100 ng/ml DNP-HSA and 2 M 1-oleoyl-2-hydroxy-sn-
glycero-3-(phospho-L-serine) (lysophosphatidylserine; Avanti
Polar Lipids, Alabaster, AL) inKrebs-Ringer solution for 10min
at 37 °C, 5% CO2. For A23187 stimulation, 5  105 cells were
stimulatedwithKrebs-Ringer solution containing 2MA23187
for 10 min at 37 °C, 5% CO2.
Quantification of Polyamine and Histamine Release—Poly-
amines were quantified by dansylation and HPLC as reported
previously with somemodifications (4, 38, 39). Briefly, 400l of
supernatant was incubated with 150 nM 1,8-diaminooctane as
an internal standard and 4.3% perchloric acid for 30min on ice.
After centrifugation at 120,000  g for 15 min at 4 °C, the
resulting supernatant was incubated with 600 l of 10 mg/ml
dansyl chloride and saturated Na2CO3 for 30 min at 60 °C and
then incubated with 10 l of 100 mg/ml L-proline for 30 min at
60 °C. Dansyl derivatives were extracted with 1.5 ml of toluene
and evaporated in a centrifugal vacuum concentrator. The
resulting pellet was resuspended with 100 l of solvent (aceto-
nitrile/water 7:3) and injected into the CAPCELL PAK 4.6
250-mm column (5 m, SHISEIDO, Tokyo, Japan).
The amount of histamine was determined as described pre-
viously (40). Briefly, cells were homogenized in PBS containing
2 M NaCl and 0.5% Triton X-100, and the soluble fraction was
obtained by centrifugation at 1000 g for 15 min at 4 °C. Per-
chloric acid (final concentration 3%) was added to the resulting
supernatant for deproteinization. The sample was subjected to
HPLC with a cation exchange column (WCX-1; Shimadzu,
Kyoto, Japan), and histamine was detected fluorometrically
through post-column derivatization with o-phthalaldehyde.
Miscellaneous Methods—SDS-PAGE and Western blotting
were performed as described (41). Protein concentrations were
determined using BSA as a standard (28). Hippocampal astro-
cyte cultures were obtained from embryonicWistar rats (em-
bryonic day 17) as described (16).
Data Analysis—All numerical values were shown as the
means S.E. unless otherwise specified. Statistical significance
was determined by two-tailed paired Student’s t test, Dunnett’s
test for multiple comparisons after analysis of variance, or one-
way repeated-measures analysis of variance followed by Dun-
nett’s test were performed using GraphPad Prism version 6
software (GraphPad Software, La Jolla, CA). Differences were
considered significant at p 0.05.
Author Contributions—K. F., S. T., T. M., H. O., Y. M., and M. H.
designed the experiments, analyzed data, and wrote the paper. T. T.,
Y. H., S. M., and M. H. performed the experiments.
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